Haemonetics CorpNYSE:HAE
- LAST PRICE89.3000
- TODAY'S CHANGE (%)-2.5100 (-2.7339%)
- Bid / Lots89.2400/ 4
- Ask / Lots89.6100/ 4
- Open / Previous Close91.2900 / 91.8100
- Day Range
- 52 Week Range
- Volume41,507
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HAE |
|---|---|---|
| 09:36 ET | 975 | 91.03 |
| 09:39 ET | 382 | 91.07 |
| 09:41 ET | 5400 | 91.155 |
| 09:45 ET | 200 | 90.925 |
| 09:48 ET | 5606 | 90.73 |
| 09:50 ET | 300 | 90.7252 |
| 09:52 ET | 688 | 90.05 |
| 09:54 ET | 200 | 90.16 |
| 09:56 ET | 100 | 90.16 |
| 09:57 ET | 400 | 89.95 |
| 10:03 ET | 200 | 89.98 |
| 10:06 ET | 2980 | 89.81 |
| 10:08 ET | 100 | 89.84 |
| 10:10 ET | 280 | 89.77 |
| 10:12 ET | 300 | 89.56 |
| 10:14 ET | 100 | 89.42 |
| 10:15 ET | 1418 | 89.63 |
| 10:17 ET | 211 | 89.715 |
| 10:21 ET | 100 | 89.465 |
| 10:24 ET | 100 | 89.24 |
| 10:26 ET | 3054 | 89.65 |
| 10:28 ET | 1078 | 89.27 |
| 10:32 ET | 400 | 89.425 |
| 10:33 ET | 100 | 89.34 |
| 10:35 ET | 1473 | 89.34 |
| 10:37 ET | 400 | 89.385 |
| 10:42 ET | 211 | 89.3 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Haemonetics Corp | 4.7B | 33.5x | +10.35% |
Lantheus Holdings Inc | 4.2B | 150.5x | -16.51% |
Neogen Corp | 4.3B | -237.6x | --- |
Merit Medical Systems Inc | 3.9B | 44.2x | +16.84% |
10X Genomics Inc | 5.3B | -28.8x | --- |
Envista Holdings Corp | 4.6B | 22.2x | -4.89% |
Company Information
Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. The Company markets and sells its products in approximately 90 countries.
Contact Information
- Headquarters
- 125 Summer StreetBOSTON, MA, United States 02110
- Phone
- 781-848-7100
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ellen Zane
- President, Chief Executive Officer, Director
- Christopher Simon
- Executive Vice President, Chief Financial Officer
- James D'arecca
- President - Global Plasma and Blood Center
- Roy Galvin
- President - Global Hospital
- Stewart Strong
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
|---|---|
Revenue (TTM) | $1.2B |
Shares Outstanding | 50.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $2.67 |
Book Value | $16.21 |
P/E Ratio | 33.5x |
Price/Sales (TTM) | 3.8 |
Price/Cash Flow (TTM) | 20.2x |
Operating Margin | 14.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
